Characterization and Prediction of Early Onset Diabetic Peripheral Neuropathy
Condition(s) studied
Investigational drug(s) / intervention(s)
Skin biopsies with quantification of intra-epidermal nerve fibre density: Skin biopsy
Perception Threshold Tracking: Transcutaneous stimulation of large and small nerve fibres using weak electrical currents
Thermal perception thresholds: Heat and cold perception thresholds
Corneal confocal Microscopy: Corneal nerve fibre density, corneal nerve fibre length, corneal nerve branch density
MRI: Functional and structural MRI pictures of peripheral nerves and CNS
Nerve conduction studies: Nerve conduction and amplitude of Sural nerve
Composite scores and questionnaires: Composite scores and questionnaires
Study summary
Predicting early onset neuropathy in people with type 1 diabetes
Eligibility
Primary outcome measure(s)
- Prediction of early onset neuropathy — 1,3,5,7,9 years
Retrospective evaluation of the predictive power for each of the diagnostic tests - Comparison of Perception Threshold Tracking (PTT) and skin biopsies — 1-2 years
Sensitivity, specificity, PPV, NPV of PTT compared to skin biopsies - Progression and regression of neuropathy — 1-9 years
Description of the natural history of the development of neuropathy
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Aalborg University Hospital | Aalborg | Denmark | Recruiting |
More Aalborg University Hospital trials in Denmark
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05546138 on ClinicalTrials.gov ↗ ← All trials in Denmark